|
Q3 Earnings call for Greenbrook
Start Date:11/11/2020
Start Time:10:00 AM EST
Duration:60 minutes
About Greenbrook TMS Inc.
Operating through 109 Company-operated treatment centers, Greenbrook is a leading provider of Transcranial Magnetic Stimulation (“TMS”), an FDA-cleared, non-invasive therapy for the treatment of Major Depressive Disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided more than 320,000 TMS treatments to over 9,000 patients struggling with depression.
If you're already registered for the Q3 Earnings call for Greenbrook webcast, click below:
ALREADY REGISTERED?
Speakers
$-[WCSpeakerDisplayHTML]-$
|
Q3 Earnings call for Greenbrook
Registration Is Closed
|
|
|
|